The Legal Battle Brewing At Liquidia With Steven & Viral
The Special Situations Report Podcast Episode 60
We’re thrilled to release this week’s special episode, an interview with not one, but two wonderful guests: Steven Kiel and Viral Kothari.
Steven Kiel is the President and Chief Investment Officer for Arquitos Capital Management, a firm he founded in 2012. He also serves on the board of directors of ENDI Corp, a holding company primarily focused on asset management. Prior to these roles, Steven served in the Army Reserves for 21 years and also served as a Trial Defense Attorney until his retirement in 2021.
Viral Kothari is a Portfolio Manager at VKKapital, and has previously worked as a Portfolio Manager at companies such as Morgan Stanley and PIMCO. He’s also worked across Wall Street in the credit space, equity and commodity option markets, and other trading operations.
Episode 60 of our weekly Special Situations Report Podcast with Steven Kiel and Viral Kothari is out today and can be found on Spotify, YouTube and Apple Podcasts.
Our conversation with Steven and Viral centered around the case for Liquidia (LQDA), a biotech company embroiled in a legal struggle with United Therapeutics (UTHR). We covered the commercial stage and Phase 3 drugs that Liquidia currently markets or is developing, the various legal cases between United Therapeutics and Liquidia, the broader PAH and PH-ILD addressable markets (the disease space in which Liquidia operates), and so much more. This was an incredibly comprehensive deep dive into a unique legal special situation, and we hope our listeners enjoy this as much as we enjoyed recording it!
You can find Steven at the following locations:
Arquitos: https://www.arquitos.com/
X/Twitter: https://x.com/Steven_Kiel
You can find Viral here:
LinkedIn: Viral Kothari
X/Twitter: https://x.com/CFAs4CFPs
Disclaimer: This podcast is for general informational and educational purposes only. The content does not constitute financial, investment, legal, or tax advice. We do not warrant the completeness or accuracy of the content or data provided in this podcast. The views, opinions, and statements expressed by guests on this podcast are their own and do not necessarily reflect the views, opinions, or positions of the hosts, producers, or affiliates of this show. The hosts’ inclusion of a guest on this podcast does not imply endorsement of the guest or their views. Nothing discussed in this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Investing involves substantial risks, including the potential loss of principal. You should conduct your own research and due diligence before making any investment decisions.